Skip to main content
OpenTrials

Clinical trial condition

Locally Recurrent

Explore clinical trials studying Locally Recurrent. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Locally Recurrent trial results

Completed

A Study of Single-Agent Eribulin Mesylate as First-Line Therapy for Locally Recurrent or Metastatic Human Epidermal Growth Factor Receptor Two (HER2) Negative Breast Cancer

NCT01268150

Conditions
Breast Diseases, Breast Neoplasms, Locally Recurrent, +5 more
Locations
  • University of Miami Miami, Florida, United States
  • Augusta Oncology Associates Augusta, Georgia, United States
  • Central Georgia Cancer Care Macon, Georgia, United States
  • Northwest Georgia Oncology Centers, P.C. Marietta, Georgia, United States
View all 17 locations
View Trial Details

Related conditions